Cell line · CVCL_2791
MKN74
Cancer cell line, Homo sapiens. Gastric tubular adenocarcinoma. 51 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. MKN74. Cell lines, record CVCL_2791. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_2791
On this page
Cell line
As Cellosaurus gives it.
- Name
- MKN74
- Accession
- CVCL_2791
- RRID
- RRID:CVCL_2791
- Synonyms
- MKN-74, MKN 74
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 37Y
- Category
- Cancer cell line
- Diseases
- Gastric tubular adenocarcinoma (NCIt C5473)
- Derived from
- Liver (metastatic)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers51
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| EIF3I reprograms iron metabolism to promote gastric cancer progression by stabilizing YAP. | Cell Mol Biol Lett | 2026 | Its Methods give the RRID and name the line | PubMed | |
| KYNU in Gastric Cancer Cells Promotes Tumor Progression by Influencing Macrophage Polarization Via PF4. | Cancer Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Yes-Associated Protein Drives Helicobacter pylori-Induced Metaplastic Changes in Gastric Epithelium. | Cell Mol Gastroenterol Hepatol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| MTSS1-dependent ubiquitin modifications mediated by FBXO44 remodel the actin cytoskeleton to promote gastric cancer progression. | Mol Cancer | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting the SOX9/TIMP1 Axis with iRGD-Conjugated Nanoplatform Enhances Dendritic Cell Function and Photodynamic Immunotherapy in Gastric Cancer. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Machine learning-based development of a cytotoxicity prediction model for NK cell therapy in cancers. | Cell Oncol (Dordr) | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Acquired vulnerability against EGF receptor inhibition in gastric cancer promoted by class I histone deacetylase inhibitor entinostat. | Neoplasia | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Enhancing the efficacy of near-infrared photoimmunotherapy through intratumoural delivery of CD44-targeting antibody-photoabsorber conjugates. | EBioMedicine | 2025 | Its Methods give the RRID and name the line | PubMed | |
| The Histone Deacetylase Inhibitor Entinostat Mediates HER2 Downregulation in Gastric Cancer, Providing the Basis for Its Particular Efficacy in HER2-Amplified Tumors and in Combination Therapies. | Cancer Res Treat | 2025 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 51
See all 51 papersRelatives2
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | MKN28 | CVCL_1416 | Has a recorded problem | Cell lines |
| Derived from it | MKN74/CMV-Luc | CVCL_4Y06 | Cell lines |
Cell banks4
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_2791
GET https://conductscience.org/api/cell-lines/v1/CVCL_2791/papers?page=2